David Hollander insider trades

Open-market stock purchases and sales by David Hollander, Chief R&D Officer at Veradermics, Inc, from SEC Form 4 filings since Nov 11, 2019.

Recent trades

DateStockTradeValue
Sep 1, 2026MANE Veradermics, IncBought (not open market)—
Sep 1, 2026MANE Veradermics, IncBought (not open market)—
Jun 10, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—

Companies traded

  • MANE Veradermics, Inc: other filings, last Sep 1, 2026
  • KPRX Kiora Pharmaceuticals Inc: other filings, last Jun 10, 2026
  • RVNC Revance Therapeutics, Inc: 1 sale, last Feb 6, 2025
  • AERI Aerie Pharmaceuticals Inc: other filings, last Feb 4, 2022

Get free alerts when David Hollander files a new trade →